- Docente: Isabella Orienti
- Credits: 11
- Language: Italian
- Moduli: Isabella Orienti (Modulo 1) Cristina Cavallari (Modulo 2) Cristina Cavallari (Modulo 3)
- Teaching Mode: In-person learning (entirely or partially) (Modulo 1); In-person learning (entirely or partially) (Modulo 2); In-person learning (entirely or partially) (Modulo 3)
- Campus: Bologna
- Corso: Long cycle 2nd degree programme in Pharmacy (cod. 0039)
Learning outcomes
The aim of this course is providing students with the knowledge
regarding innovative pharmaceutical formulations, nanoparticulate
systems and modified drug release. Moreover the course will provide
knowledge about the main aspects drug of bioavailability correlated
with the characteristics of the excipients in the pharmaceutical
formulation. Laboratory activity will also be provided to support
the learning activity.
Course contents
1st Module Prof.ssa I. Orienti
Pharmacokinetic models for the drug distribution in the
body
Pharmaceutical dosage forms and pharmaceutical systems. Factors
influencing drug absorption and drug availability.
Pharmacokinetics. Plasma concentration –time curves. Absolute
bioavailability. Relative bioavailability. Bioequivalence. Dose
size and frequency of administration.
Conventional drug delivery systems Formulative and
preparative aspects correlable with the administration route and
the release characteristics of the pharmaceutical formulation.
Dissolution. Partition. Methods to modify the drug dissolution and
partition from the conventional pharmaceutical formulations.
Modified release drug delivery
systems. Physico-chemical properties of the excipients
correlable with the release characteristics.Diffusion controlled
devices. Monolithic devices. Reservoir devices. Solvent controlled
devices. Osmotically controlled devices. Swelling controlled
devices. Chemically controlled devices.
Innovative pharmaceutical formulations. Micro and
nanoparticulate systems. Macromolecular systems. Liposomes.
Micelles. Formulative, preparative physico-chemical and functional
characteristics correlable to their utilization in the
conventional, controlled, modified release or in passive and active
drug targeting.
2nd module Dott.ssa Cristina Cavallari
The pharmaceutical technologist. Development of a pharmaceutical
form. Good practices for pharmaceutical development. Laboratory of
Pharmaceutical development.
pre-formulative Developments. Chemical stability. compatibility and
interactions.
Nature of the physical state of drugs and excipients
The polymorph state. The amorphous state. The glass transition
temperature. Stabilizing the amorphous state.
Analysis of the solid state: Thermal analysis: DSC, TGA, and HSM.
X-ray diffraction
Routes of administration of drugs. Pharmaceutical forms for oral
use: pellets (production methods and technologies), capsules and
effervescent tablets. . Preparations for parenteral use.
Pharmaceutical forms can be administered by transmucosal: prepared
for nasal administration, pulmonary, ocular, buccal and
vaginal
Gastro-resistant pharmaceutical forms: Examples and materials
used
Release oral pharmaceutical forms: colon-specific systems
Route of administration of ophthalmic drugs.
The inhalation of dust and aerosols.
The orodispersible formulations.
The vaginal preparations
Polymers of pharmaceutical interest: Polyvinylpirrolidone (PVP),
Polyethylenglicols (PEG), poloxamers; acrylic polymers (Carbopol
and EUDRAGIT).
Polysaccharide polymers: cellulose, derivatives (HPMC) and
chitosan.
Taste masking of oral pharmaceutical forms.
Freeze drying: process description, formulation and
development.
3th Module
Laboratories
1: Preparing a mucilage base
Preparation of a wet granulate; using granulator
Preparing oleogel and hydrogel
Uniformity of weight of tablets
2: Dimensional analysis using sieves, vibrating screen
Measuring angle of repose of a granular material
Prepare a paste and demonstration of the Refiner
Preparing emulgel
3: Measurement of the density of a powder with a hydrometer
Monsanto hardness tester
Friabilometer
De-aggregator
Preparation of an emulsion and analysis using Microscope
Suppositories with the method of the double fusion
4: Manual Capsule filling machine (and uniformity of mass on the capsules)
Demonstration and explanation of the operation of the tabletting machine
Measurement of the content of a tablet using spectrophotometer
Readings/Bibliography
- SWARBRICK, BOYLAN, Encyclopedia of Pharmaceutical Technology, Dekker, 1999-2005.
- P. Colombo, P. Castellani, A. Gazzaniga, E. Menegatti, E.
Vidale, Principles of Pharmaceutical Technology, Casa Editrice
Ambrosiana, Milan, 2004.
- A. T. Florence, D. Attwood, chemical and physical bases of
Pharmaceutical Technology, EdiSES Srl, Naples, 2006.
- Handbook of pharmaceutical excipients, 6th ed. Edited by Raymond
C. Rowe, Paul J. Sheskey, Sian C. Owen, Pharmaceutical Press and
American Pharmacists Association, Chicago, 2009
Teaching methods
Lesson and laboratory practice / exercises
Assessment methods
1st Module
The Assessment of the first module occurs only with the final
exam, which ensures the acquisition of knowledge and skills
expected by conducting a written test lasting 1 hour.
The final exam test is intended to verify the achievement of the
following objectives:
Knowledge of the main functional differences among the different pharmaceutical formulations in relation to the physico-chemical characteristics of the excipients and the preparative methods. Correlations between drug release and administration environment. Evaluation methods for drug release. Correlations between release kinetics and bioavailability. Methods to improve bioavailability. Preparative methods for micro/nano particulate drug delivery systems and their functional evaluation.
The written test will consist of 16 questions with multiple choice answer. It will last 1 hour and the final evaluation will be done by assigning +2 to each correct answer, - 1 to each wrong or unanswered question.
2nd Module
The Assessment of the second module occurs only with the final
exam, which ensures the acquisition of knowledge and skills
expected by conducting a written test lasting 2 hours without the
aid of notes or books, followed by a oral examination in character
(optional).
The final exam test is intended to verify the achievement of the
following objectives:
Basic principles necessary to the formulation, production of oral
pharmaceutical forms, pellets, capsules and effervescent tablets.
for nasal, buccal, ophthalmic, vaginal and targeted to the colon as
well as a deeper understanding of some excipients commonly used in
pharmaceutical technology.
The written test, preparatory to the oral one, consists of 3
open-ended questions
Teaching tools
power point
Office hours
See the website of Isabella Orienti
See the website of Cristina Cavallari
See the website of Cristina Cavallari